Our last year paper provide further insight to this https://t.co/FEG8P6fRer
1,094 followers
1,001 followers
RT @KynTherapeutics: #ICYMI Our CEO @markgmanfredi, @LIMR_'s George Prendergast and other experts talk next steps in #IDO inhibition after…
49,516 followers
RT @KynTherapeutics: #ICYMI Our CEO @markgmanfredi, @LIMR_'s George Prendergast and other experts talk next steps in #IDO inhibition after…
1,167 followers
#ICYMI Our CEO @markgmanfredi, @LIMR_'s George Prendergast and other experts talk next steps in #IDO inhibition after the ECHO-301 trial in a recent publication from Seminars in #Immunopathology. More here: https://t.co/GqVHpXiMSN #immunotherapy https://t.